Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 13:148:e300.
doi: 10.1017/S0950268820002745.

Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey

Affiliations

Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey

M Shakiba et al. Epidemiol Infect. .

Abstract

The prevalence of asymptomatic infection by coronavirus disease 2019 (COVID-19) as a critical measure for effectiveness of mitigation strategy has been reported to be widely varied. In this study, we aimed to determine the prevalence of asymptomatic infection using serosurvey on general population. In a cross-sectional seroprevalence survey in Guilan province, Iran, the specific antibody against COVID-19 in a representative sample was detected using rapid test kits. Among 117 seropositive subjects, prevalence of asymptomatic infection was determined based on the history of symptoms during the preceding 3 months. The design-adjusted prevalence of asymptomatic infection was 57.2% (95% confidence interval (CI) 44-69). The prevalence was significantly lower in subjects with previous contacts to COVID-19 patients (12%, 95% CI 2-49) than others without (69%, 95% CI, 46-86). The lowest prevalence was for painful body symptom (74.4%). This study revealed that more than half of the infected COVID-19 patients had no symptoms. The implications of our findings include the importance of adopting public health measures such as social distancing and inefficiency of contact tracing to interrupt epidemic transmission.

Keywords: Asymptomatic infection; SARS-CoV-2; seroprevalence.

PubMed Disclaimer

References

    1. Lee S et al. (2020) Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea. JAMA Internal Medicine 180(11), 1–6. - PMC - PubMed
    1. Zou L et al. (2020) SARS-CoV-2 viral load in upper respiratory specimens of infected patients. The New England Journal of Medicine 382, 1177–1179. - PMC - PubMed
    1. Chen Y et al. (2020) Epidemiological characteristics of infection in COVID-19 close contacts in Ningbo city. Zhonghua liu xing bing xue za zhi 41, 667–671. - PubMed
    1. Wang X et al. (2020) The impact of asymptomatic individuals on the strength of public health interventions to prevent the second outbreak of COVID-19. Nonlinear Dynamics, 1–10. - PMC - PubMed
    1. Oran DP and Topol Ej (2020). Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review. Annals of Internal Medicine 173(5), 362–367. - PMC - PubMed

Publication types